ELP5 and colorectal carcinoma: Eight were down-regulated in AA vs. EA CRC patients; VSIG10L, p = 0.015; C17orf81, p = 0.032; WDR8, p = 0.002; TRNT1, p = 0.004; ANKRD36B, p = 0.044; ARHGAP6, p = 0.049; ADAL, p = 0.074; ZNF83, p = 0.11; (Fig. 3; Panel B.).